Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
Clinical trial NCT02342548 · TERMINATED
Trial details
- NCT number
- NCT02342548
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-25
- Primary completion
- 2017-02-06
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.